Abiopharma

COHEN & CO INC. (COHN)

Symbol	COHN
Name	COHEN & CO INC.
Sector	FINANCE
Region	North America
Industry	Security Brokers, Dealers & Flotation Companies
Address	CIRA CENTRE, 2929 ARCH STREET, PHILADELPHIA, PA 19104-2870
Telephone	215-701-9555
Fax	—
Email	—
Website	https://www.cohenandcompany.com
Incorporation	UNDEFINED
Incorporated On	—
Employees	—
Fiscal Year	—
Public Since	—
Exchanges	NASDAQ
Auditor	—
Audit Status	NOT PROVIDED
Reporting Status	—
CIK	0001270436
Description	Cohen & Co Inc is a US-based company that delivers financial services in fixed income markets. It is focused on small-cap banking institutions and has grown to provide an expanding range of capital markets and asset management services. It has three business segments. The Capital Markets segment, which is the key revenue driver, consists of fixed income sales, trading, matched book repo financing, new issue placements in corporate and securitized products, and advisory services. The Asset Management segment manages assets within collateralized debt obligations, managed accounts, joint ventures, and investment funds. The Principal Investing segment is comprised of investments to earn return rather than to support trading, matched book repo, or other Capital Markets segment activities. Additional info from NASDAQ: Cohen & Co Inc is a US-based company that delivers financial services in fixed income markets. It is focused on small-cap banking institutions and has grown to provide an expanding range of capital markets and asset management services. It has three business segments. The Capital Markets segment, which is the key revenue driver, consists of fixed income sales, trading, matched book repo financing, new issue placements in corporate and securitized products, and advisory services. The Asset Management segment manages assets within collateralized debt obligations, managed accounts, joint ventures, and investment funds. The Principal Investing segment is comprised of investments to earn return rather than to support trading, matched book repo, or other Capital Markets segment activities.

2026-07-30 20:15

Cohen & Company Sets Release Date for Second Quarter 2026 Financial Results

2026-07-17 20:05

Director COHEN DANIEL G 🔴 sold 17.6K shares of Cohen & Co Inc. (COHN) Transaction Date: Jul 17, 2026 | Filing ID: 084618

2026-06-22 20:06

(99% Neutral) COHEN & CO INC. (COHN) Announces Business Combination

2026-06-08 12:15

Cohen & Company Securities Opens Charlotte Office

2026-06-03 07:05

New Form EFFECT - Cohen & Co Inc. Filed: 2026-06-02 AccNo: 9999999995-26-001852 Size: 2 KB

2026-05-27 20:05

(99% Neutral) COHEN & CO INC. (COHN) Reports Q2 2026 Financial Results

2026-05-18 17:55

New Form S-3 - Cohen & Co Inc. Filed: 2026-05-18 AccNo: 0001104659-26-063252 Size: 395 KB

2026-05-01 12:00

Cohen & Company Reports First Quarter 2026 Financial Results

2026-04-29 20:15

Cohen & Company Sets Release Date for First Quarter 2026 Financial Results

2026-04-24 15:14

Director COHEN DANIEL G 🔴 sold 8.0K shares of Cohen & Co Inc. (COHN) Transaction Date: Apr 23, 2026 | Filing ID: 048375